Precision BioLogic, a Halifax medtech company that sells diagnostic testing supplies, has launched a new product for the bleeding disorder Hemophilia B.
The Hemophilia test, recently approved by Health Canada, is in response to increasing market demand for chromogenic assays and is the only Hemophilia B test of its kind available in the country, Precision said in a statement. Chromogenic assays measure the clotting properties of blood using coloured substrates — the substance on which an enzyme, such as those that aid in blood clotting, acts.
Founded in 1992, Precision sells a raft of